Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone disorders in cholestatic liver diseases

G Isaia1, M Di Stefano, C Roggia

  • 1Department of Internal Medicine, University of Turin, Turin, Italy.

Forum (Genoa, Italy)
|June 17, 1998
PubMed
Summary

Osteopenia is a common complication of cholestatic liver diseases (CLD), often leading to fractures. This review covers prevalence, diagnosis, causes, and treatments for bone density loss in CLD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Starving for oxygen: the effect of hypoxia on seed germination and secondary dormancy induction in Mediterranean temporary ponds plant species.

Plant biology (Stuttgart, Germany)·2025
Same author

Diffusion MRI of the prenatal fetal brain: a methodological scoping review.

NeuroImage·2025
Same author

Transient loss of Polycomb components induces an epigenetic cancer fate.

Nature·2024
Same author

Two nasal swabs may not be enough to exclude SARS-CoV-2 infection in symptomatic patients.

Annali di igiene : medicina preventiva e di comunita·2021
Same author

The informative experience of endocrine residents with COVID-19.

Journal of endocrinological investigation·2020
Same author

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment.

Journal of endocrinological investigation·2020

Area of Science:

  • Hepatology
  • Endocrinology
  • Bone Metabolism

Background:

  • Osteopenia is a frequent complication of cholestatic liver diseases (CLD), impacting 10-56% of patients.
  • Primary biliary cirrhosis (PBC) is most commonly associated with osteopenia, but other CLDs like PSC and alcoholic liver disease also contribute.
  • The exact mechanisms causing bone disease in chronic cholestasis remain unclear, with ongoing debate about osteomalacia versus osteoporosis.

Purpose of the Study:

  • To review the prevalence, diagnostic methods, pathophysiology, and treatment strategies for osteopenia in patients with cholestatic liver diseases.
  • To consolidate current understanding of bone disease in chronic cholestasis.
  • To highlight the clinical significance of osteopenia in CLD, particularly concerning fracture risk.

Main Methods:

  • Literature review of studies on osteopenia in cholestatic liver diseases.
  • Analysis of prevalence data across different CLDs.
  • Discussion of diagnostic tools including bone mineral density measurements and laboratory tests.
  • Synthesis of current knowledge on the pathogenesis and treatment of bone disease in CLD.

Main Results:

  • Osteopenia is a significant complication of CLD, with varying prevalence depending on the specific liver condition.
  • Bone mineral density measurement is crucial for assessing osteopenia severity in CLD.
  • Laboratory tests provide insights into the metabolic bone status.
  • Osteopenia increases the risk of atraumatic fractures, especially in PBC patients post-liver transplantation on corticosteroids.

Conclusions:

  • Osteopenia is a prevalent and serious complication of cholestatic liver diseases requiring careful management.
  • Accurate diagnosis through bone density assessment and laboratory tests is essential.
  • Further research is needed to fully elucidate the pathogenesis and optimize treatment strategies for bone disease in CLD.

Related Experiment Videos